Evidence map›Paper›PMID 35561130›Full record

ArticleDiabetes care2022

Individualized Glycemic Goals for Older Adults Are a Moving Target.

Scott J Pilla, Zhinous Shahidzadeh Yazdi, Simeon I Taylor

Abstract readComment
In one paragraph

Article in Diabetes care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Scott J PillaDivision of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.ORCID 0000-0002-3292-9047
Zhinous Shahidzadeh YazdiDivision of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
Simeon I TaylorDivision of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.ORCID 0000-0001-7500-7854

Funding

U.S. Deprescribing Research NetworkR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BOYD, CYNTHIA MELINDA, STEINMAN, MICHAEL A. · 2019 to 2023
$9.9M
Genetics of Response to CanagliflozinR01DK118942 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI BEITELSHEES, AMBER L, TAYLOR, SIMEON I. · 2018 to 2022
$3.5M
Pharmacogenetics of the Response to a GLP1R AgonistR01DK130238 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI AMBER L BEITELSHEES, SIMEON I. TAYLOR · 2022 to 2026
$3.3M
Diabetes, Obesity, and Metabolic ComplicationsT32DK098107 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI TAYLOR, SIMEON I. · 2015 to 2025
$2.4M
An intervention to enhance hypoglycemia communication and preventive action in primary careK23DK128572 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI PILLA, SCOTT · 2021 to 2024
$790k
NIA NIH HHS R24 AG064025NIDDK NIH HHS K23 DK128572NIDDK NIH HHS R01 DK118942NIDDK NIH HHS R01 DK130238NIDDK NIH HHS T32 DK098107
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2GoalsAgedBlood GlucoseGlycated HemoglobinHumansHypoglycemic AgentsBlood GlucoseGlycated HemoglobinHypoglycemic Agents

Identifiers

PMID35561130
PMCPMC9375443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.